POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Enacted

Oklahoma requires Medicaid to cover rapid whole genome sequencing for critically ill children

Original title: Medicaid; terms; Oklahoma Health Care Authority; coverage; Medicaid; criteria; medical necessity; discretion; Chief Operating Officer; Health Information Portability and Accountability Act; scientific research; consent; research; opting-out; minors; promulgation of rules and regulations; waiver application; effective date; emergency.

Last action · May 30, 2025: To SenateSponsors: Danny Williams and 1 other

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

Oklahoma House Bill 1576 requires the Oklahoma Health Care Authority to cover as a separately payable Medicaid service for hospitalized patients under twenty-one years of age with complex or acute illnesses of unknown , pending federal approval. The measure establishes strict medical necessity criteria, protects genetic data under HIPAA, permits data use in scientific research only with explicit consent, and takes effect July 1, 2025, with an emergency clause.

Why it matters

Hospitalized Medicaid-enrolled minors with undiagnosed acute conditions gain access to genetic testing coverage that returns preliminary results within seven days, while families retain the right to withdraw consent for scientific research use at any time.

Background
  • The Oklahoma Health Care Authority is the state agency that administers Oklahoma's Medicaid program, known as SoonerCare. context

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Medicaid beneficiaries

Minors under twenty-one enrolled in Medicaid gain access to covered rapid whole genome sequencing when hospitalized with acute, undiagnosed illnesses.

Directly affected

Oklahoma Health Care Authority

The agency is required to provide coverage, seek necessary federal approvals, and promulgate rules and regulations to implement the testing mandate.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Who is eligible for Medicaid-covered rapid whole genome sequencing under this bill?
Medicaid beneficiaries under twenty-one years of age who have a complex or acute illness of unknown and are receiving hospital services in an intensive care unit or other high-acuity care unit.
Can my child's genetic data be used for scientific research without my permission?
No. Genetic data generated from the testing can only be used in scientific research if explicit consent has been given by the patient or the patient's legal guardian.
What happens if I give consent for research and later change my mind?
You or your legal guardian have the right to rescind the consent at any time. Upon receiving a written revocation, the health care provider or other entity must stop using the data and delete it from any data repository.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Current status: Became law over the governor's veto.

Procedural history

50 actions
  1. May 30, 2025House
    To Senate
  2. May 30, 2025House
    Veto overridden: Ayes: 76 Nays: 12
  3. May 29, 2025House
    Filed with Secretary of State
  4. May 29, 2025Senate
    Measure returned to House
  5. May 29, 2025Senate
    Veto overridden: Ayes: 36 Nays: 9
  6. May 28, 2025House
    Vetoed 05/28/2025
Show 44 earlier actions
  1. May 22, 2025House
    Sent to Governor
  2. May 22, 2025Senate
    Enrolled measure signed, returned to House
  3. May 22, 2025House
    Enrolled, signed, to Senate
  4. May 22, 2025HouseCommittee
    Referred for enrollment
  5. May 22, 2025Senate
    Emergency passed, to House: Ayes: 39 Nays: 3
  6. May 22, 2025SenateFloor
    Measure passed, to House: Ayes: 27 Nays: 15
  7. May 22, 2025SenateFloor
    CCR adopted, GCCA
  8. May 22, 2025Senate
    CCR read, GCCA
  9. May 22, 2025House
    To Senate
  10. May 22, 2025House
    Fourth Reading, Measure and Emergency Passed: Ayes: 68 Nays: 21
  11. May 22, 2025HouseFloor
    CCR adopted
  12. May 21, 2025House
    Enacting clause restored
  13. May 21, 2025House
    Title restored
  14. May 21, 2025House
    Coauthored by Representative(s) Cantrell, Williams
  15. May 21, 2025House
    CCR submitted
  16. May 15, 2025Senate
    Conference granted, GCCA
  17. May 15, 2025HouseCommittee
    HC's named: Conference Committee on Health and Human Services Oversight
  18. May 14, 2025House
    SA's rejected, conference requested, conferees to be named later
  19. May 12, 2025House
    SA's received
  20. May 12, 2025Senate
    Engrossed to House
  21. May 8, 2025SenateCommittee
    Referred for engrossment
  22. May 8, 2025Senate
    Emergency passed: Ayes: 45 Nays: 1
  23. May 8, 2025SenateFloor
    Measure passed: Ayes: 33 Nays: 13
  24. May 8, 2025Senate
    General Order, Considered
  25. Apr 28, 2025Senate
    Placed on General Order
  26. Apr 23, 2025SenateFloor
    Reported Do Pass Appropriations committee; CR filed
  27. Apr 7, 2025SenateCommittee
    Referred to Appropriations
  28. Apr 7, 2025Senate
    Enacting clause stricken
  29. Apr 7, 2025SenateFloor
    Reported Do Pass as amended Health and Human Services committee; CR filed
  30. Apr 1, 2025SenateCommittee
    Second Reading referred to Health and Human Services Committee then to Appropriations Committee
  31. Mar 4, 2025SenateIntroduced
    First Reading
  32. Mar 4, 2025House
    Engrossed, signed, to Senate
  33. Mar 3, 2025HouseCommittee
    Referred for engrossment
  34. Mar 3, 2025House
    Third Reading, Measure and Emergency passed: Ayes: 83 Nays: 14
  35. Mar 3, 2025House
    Title stricken
  36. Mar 3, 2025House
    Amended
  37. Mar 3, 2025House
    General Order
  38. Feb 26, 2025HouseFloor
    CR; Do Pass Health and Human Services Oversight Committee
  39. Feb 5, 2025House
    Authored by Senator Hicks (principal Senate author)
  40. Feb 5, 2025HouseFloor
    Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health
  41. Feb 4, 2025HouseCommittee
    Referred to Public Health
  42. Feb 4, 2025HouseCommittee
    Second Reading referred to Health and Human Services Oversight
  43. Feb 3, 2025House
    Authored by Representative Lawson
  44. Feb 3, 2025HouseIntroduced
    First Reading

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift95% confidence

Mandated Genetic Testing Coverage

The measure establishes rapid whole genome sequencing as a separately payable Medicaid service, setting statutory definitions and explicit clinical criteria for high-acuity pediatric patients.

Connected Entities

Oklahoma Health Care Authority, Josh Cantrell, Danny Williams and 2 more
OrganizationOklahoma Health Care Authority“State agency required to provide Medicaid coverage for rapid whole genome sequen”Map →
PersonJosh Cantrell“Legislative coauthor”Map →
PersonDanny Williams“Primary legislative sponsor of the bill in the House”Map →
OrganizationCenters for Medicare and Medicaid Services“Federal agency whose approval may be required for implementation”Map →
PersonHicks“Senate sponsor”Map →

Sources

Open source document

www.oklegislature.gov

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy15
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record